AURA Aura Biosciences, Inc.

Healthcare [ 2/11 ] | Biotechnology [ 31/156 ]

US | NASDAQ | Stock

Price: $10.21

Decreased by -0.01%
Dollar Volume: 1.39 M
ADR%: 5.06
Earnings Report Date (estimate): Mar 15, 23 (-0.58)

Market Cap.: 378.18 M
Shares Float: 14.67 M
Shares Outstanding: 37.04 M

Beta: 0.00
Price / Earnings: -5.46
BPR: 26.88

20D Range: 9.50 10.96
50D Range: 9.50 12.31
200D Range: 9.43 24.83

Quarterly Earnings
Annual Earnings

Reported Date	EPSChange YoY	EstimateSurprise
Nov 10, 22	-0.54	-0.51 Decreased by -11.53%
Aug 11, 22	-0.46	-0.46
May 12, 22	-0.44	-0.44

Quarterly Financials
Annual Financials

Fiscal ending date	RevenueChange YoY	IncomeChange YoY	ProfitChange YoY
Sep 30, 22	0.00 Decreased by N/A%	-15.90 M Decreased by -79.92%	Decreased by N/A% Decreased by N/A%
Jun 30, 22	0.00 Decreased by N/A%	-13.47 M Decreased by -52.15%	Decreased by N/A% Decreased by N/A%
Mar 31, 22	0.00 Decreased by N/A%	-12.84 M Decreased by -116.55%	Decreased by N/A% Decreased by N/A%
Dec 31, 21	0.00 Decreased by N/A%	0.00 Increased by +100.00%	Decreased by N/A% Decreased by N/A%
Sep 30, 21	0.00 Decreased by N/A%	-8.84 M Decreased by -143.40%	Decreased by N/A% Decreased by N/A%
Jun 30, 21	0.00 -	-8.85 M -	Decreased by N/A% -
Mar 31, 21	0.00 -	-5.93 M -	Decreased by N/A% -
Dec 31, 20	0.00 -	-4.91 M -	Decreased by N/A% -

Top 20 ETF Stock Exposure
Top 20 Institutional Holders
Top 20 Mutual Fund Holders

Rank	ETF	Shares	Market Value	Weight % in ETF

DAILY

WEEKLY

MONTHLY

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.